It is well known that the IDO enzyme, which converts tryptophan, an essential amino acid, into Kyn, inhibits cells such as CD8+ T cells, NK cells, and macrophages, activates regulatory T cells, and has positive effects on tumor progression (Mbongue et al., 2015; Zhai et al., 2020). This evidence concerns the gene IDO1 and neoplasm.